Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, Pakistan.
J Clin Lab Anal. 2010;24(5):348-56. doi: 10.1002/jcla.20417.
Cardiac diseases are the major cause of death. Paraoxonase1 (PON1) is known as free radicals scavenger/anti-atherosclerosis, whereas xanthine oxidase (XO) is a free radicals generator. This study was undertaken to determine and compare the Paraoxonase and arylesterase activities of PON1 enzyme and activity of XO enzyme. The concentration of XO and PON1 enzymes along with lipid profile, lipid peroxides, and thiol level in plasma of cardiac patients (n=200) and healthy persons (n=200) of Lahore metropolitan, Pakistan was also determined. Anti-PON1 and anti-XO antibodies were developed, purified, and used to measure the concentration of PON1 and XO by competitive ELISA. It is observed that low paraoxonase (P=0.0073)/arylesterase activity (P=0.0038) of PON1 enzyme and its low concentration (P=0.0049) were observed in cardiac patients, whereas elevated level of XO activity (P=0.0129) and its concentration (P=0.0097) was observed in cardiac patients as compared with healthy persons. Low levels of HDL (P=0.0013), thiol (P=0.0014) and high level of cholesterol (P=0.0025), triglycerides (P=0.0018), LPO (P=0.0014), and LDL level (P=0.05) were observed in cardiac patients admitted in intensive care unit as compared with hypertensive patients and control subjects. It is concluded that overall low PON1 and high XO activities do cause imbalance of free radical system which ultimately leads to or enhance the cardiac pathological conditions.
心脏病是主要的死亡原因。对氧磷酶 1(PON1)被认为是自由基清除剂/抗动脉粥样硬化,而黄嘌呤氧化酶(XO)是自由基的产生者。本研究旨在确定和比较 PON1 酶的对氧磷酶和芳基酯酶活性以及 XO 酶的活性。还测定了巴基斯坦拉合尔大都市的心脏病患者(n=200)和健康人(n=200)血浆中 XO 和 PON1 酶的浓度以及血脂谱、脂质过氧化物和巯基水平。制备、纯化了抗 PON1 和抗 XO 抗体,并通过竞争性 ELISA 用于测量 PON1 和 XO 的浓度。结果观察到,心脏病患者的 PON1 酶的低对氧磷酶(P=0.0073)/芳基酯酶活性(P=0.0038)及其低浓度(P=0.0049),而 XO 活性(P=0.0129)及其浓度(P=0.0097)升高。与健康人相比,心脏病患者的 HDL(P=0.0013)、巯基(P=0.0014)水平较低,胆固醇(P=0.0025)、甘油三酯(P=0.0018)、LPO(P=0.0014)和 LDL 水平(P=0.05)升高。与高血压患者和对照组相比,入住重症监护病房的心脏病患者的 PON1 和 XO 活性较低,自由基系统失衡,最终导致或加重心脏病理状况。